3.8 Review

Antimicrobial resistance: the good, the bad, and the ugly

Journal

EMERGING TOPICS IN LIFE SCIENCES
Volume 4, Issue 2, Pages 129-136

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/ETLS20190194

Keywords

-

Funding

  1. European Union [15HLT01]
  2. National Biofilms Innovation Centre (NBIC) - Biotechnology and Biological Sciences Research Council
  3. Innovate UK
  4. Hartree Centre

Ask authors/readers for more resources

As the Royal Society for Biology (RSB) was forming 10 years ago, antimicrobial resistance (AMR) was being heralded as the next threat with a magnitude on a par with global warming. Just a few years later, in 2016, Jim O'Neill's report was published laying out recommendations for tackling drug-resistant infections globally. Where are we now, and what are the challenges ahead? As a slow burner, how will the impact of AMR compare against the recent rapid devastation of the COVID-19 pandemic, and how can we channel some of the good things that come from it (like the awareness and technique of effective hand hygiene) to help us combat AMR speedily and definitively?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available